hexamethonium has been researched along with Carcinoma, Hepatocellular in 1 studies
Hexamethonium: A nicotinic cholinergic antagonist often referred to as the prototypical ganglionic blocker. It is poorly absorbed from the gastrointestinal tract and does not cross the blood-brain barrier. It has been used for a variety of therapeutic purposes including hypertension but, like the other ganglionic blockers, it has been replaced by more specific drugs for most purposes, although it is widely used a research tool.
Carcinoma, Hepatocellular: A primary malignant neoplasm of epithelial liver cells. It ranges from a well-differentiated tumor with EPITHELIAL CELLS indistinguishable from normal HEPATOCYTES to a poorly differentiated neoplasm. The cells may be uniform or markedly pleomorphic, or form GIANT CELLS. Several classification schemes have been suggested.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hsu, JP | 1 |
| Ku, MH | 1 |
| Yang, LC | 1 |
| Lu, JN | 1 |
| Young, TH | 1 |
| Tseng, S | 1 |
1 other study available for hexamethonium and Carcinoma, Hepatocellular
| Article | Year |
|---|---|
Electrophoretic behaviors of human hepatoma HepG2 cells.
Topics: Algorithms; Buffers; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Membrane; Electromagnetic Fie | 2009 |